Literature DB >> 23068562

Role of respiratory-gated PET/CT for pancreatic tumors: a preliminary result.

Takeo Kasuya1, Ukihide Tateishi, Kazufumi Suzuki, Hiromitsu Daisaki, Yuji Nishiyama, Masaharu Hata, Tomio Inoue.   

Abstract

PURPOSE: The aim of this study is to ascertain role of respiratory-gated PET/CT for accurate diagnosis of pancreatic tumors.
MATERIALS AND METHODS: Prior to clinical study, the phantom study was performed to evaluate the impact of respiratory motion on lesion quantification. Twenty-two patients (mean age 65 years) with pancreatic tumors were enrolled. Pathological diagnoses by surgical specimens consisted of pancreatic cancer (n=15) and benign intraductal papillary mucinous neoplasm (IPMN, n=7). Whole-body scan of non-respiratory-gated PET/CT was performed at first, and subsequent respiratory-gated PET/CT for one bed position was performed. All PET/CT studies were performed prior to surgery. The SUV max obtained by non-respiratory-gated PET/CT and respiratory-gated PET/CT, and percent difference in SUVmax (%SUVmax) were compared.
RESULTS: The profile curve of 5 respiratory bin image was most similar to that of static image. The third bin of 5 respiratory bin image showed highest FWHM (24.0mm) and FWTM (32.7 mm). The mean SUVmax of pancreatic cancer was similar to that of benign IPMN on non-respiratory-gated PET/CT (p=0.05), whereas significant difference was found between two groups on respiratory-gated PET/CT (p=0.016). The mean %SUV of pancreatic cancer was greater than that of benign IPMN (p<0.0001). Identification of the primary tumor in pancreatic head (n=13, 59%) was improved by using respiratory-gated PET/CT because of minimal affection of physiological accumulation in duodenum.
CONCLUSION: Respiratory-gated PET/CT is a feasible technique for evaluation of pancreatic tumors and allows more accurate identification of pancreatic tumors compared with non-respiratory-gated PET/CT.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23068562     DOI: 10.1016/j.ejrad.2012.05.037

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  6 in total

Review 1.  Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer.

Authors:  Xiao-Yi Wang; Feng Yang; Chen Jin; De-Liang Fu
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 2.  Respiratory-gated PET/CT for pulmonary lesion characterisation-promises and problems.

Authors:  Russell Frood; Garry McDermott; Andrew Scarsbrook
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

Review 3.  Management of respiratory motion in PET/computed tomography: the state of the art.

Authors:  Audrey Pépin; Joël Daouk; Pascal Bailly; Sébastien Hapdey; Marc-Etienne Meyer
Journal:  Nucl Med Commun       Date:  2014-02       Impact factor: 1.690

4.  The use of positron emission tomography/computed tomography imaging in radiation therapy: a phantom study for setting internal target volume of biological target volume.

Authors:  Wataru Kawakami; Akihiro Takemura; Kunihiko Yokoyama; Kenichi Nakajima; Syoichi Yokoyama; Kichiro Koshida
Journal:  Radiat Oncol       Date:  2015-01-08       Impact factor: 3.481

5.  Respiratory 4D-Gating F-18 FDG PET/CT Scan for Liver Malignancies: Feasibility in Liver Cancer Patient and Tumor Quantitative Analysis.

Authors:  Anson H Y Cheung; Vincent W C Wu; Andy L Y Cheung; Jing Cai
Journal:  Front Oncol       Date:  2022-02-09       Impact factor: 6.244

6.  Usefulness of respiratory-gated PET acquisition during delayed 18F-FDG PET/CT scanning for patients with liver metastases.

Authors:  Shota Watanabe; Kohei Hanaoka; Hayato Kaida; Tomoko Hyodo; Minoru Yamada; Masakatsu Tsurusaki; Kazunari Ishii
Journal:  Asia Ocean J Nucl Med Biol       Date:  2021
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.